Cargando…
Reducing Immunosuppression in Patients with De Novo Lung Carcinoma after Liver Transplantation Could Significantly Prolong Survival
SIMPLE SUMMARY: Long-term immunosuppressive therapy following liver transplantation is associated with an increased risk for the development of de novo lung carcinoma. However, data on the management of the immunosuppression following the diagnosis of lung cancer are missing to the present day. In t...
Autores principales: | Pesthy, Sina, Wegener, Elisa, Ossami Saidy, Ramin Raul, Timmermann, Lea, Uluk, Deniz, Aydin, Mustafa, Dziodzio, Tomasz, Schoening, Wenzel, Lurje, Georg, Öllinger, Robert, Frost, Nikolaj, Fehrenbach, Uli, Rückert, Jens-Carsten, Neudecker, Jens, Pratschke, Johann, Eurich, Dennis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179580/ https://www.ncbi.nlm.nih.gov/pubmed/35681728 http://dx.doi.org/10.3390/cancers14112748 |
Ejemplares similares
-
A Reduction of Calcineurin Inhibitors May Improve Survival in Patients with De Novo Colorectal Cancer after Liver Transplantation
por: Ossami Saidy, Ramin Raul, et al.
Publicado: (2022) -
The Role of Immunosuppression for Recurrent Cholangiocellular Carcinoma after Liver Transplantation
por: Gül-Klein, Safak, et al.
Publicado: (2022) -
How to Estimate the Probability of Tolerance Long-Term in Liver Transplant Recipients
por: Eurich, Dennis, et al.
Publicado: (2023) -
Successful implementation of preventive measures leads to low relevance of SARS‐CoV‐2 in liver transplant patients: Observations from a German outpatient department
por: Ossami Saidy, Ramin Raul, et al.
Publicado: (2020) -
Minimization of Immunosuppressive Therapy Is Associated with Improved Survival of Liver Transplant Patients with Recurrent Hepatocellular Carcinoma
por: Ossami Saidy, Ramin Raul, et al.
Publicado: (2021)